Nanomaterials In Personalized Medicine Global Market Report 2025

Description

Nanomaterials in personalized medicine are highly engineered substances at the nanoscale, designed to interact with biological systems precisely and in a controlled manner. They enable healthcare interventions to be tailored to an individual's specific genetic, molecular, or physiological characteristics. These nanomaterials enhance therapeutic effectiveness, minimize potential side effects, and improve overall patient outcomes by supporting targeted, controlled, and individualized medical interventions.

The primary types of nanomaterials in personalized medicine include carbon-based nanomaterials, metallic nanoparticles, polymeric nanomaterials, nanostructured materials, and silica nanoparticles. Carbon-based nanomaterials consist of tiny structures primarily made of carbon, such as graphene, carbon nanotubes, and fullerenes. They are available in various formulations, including nanoparticles, nanosuspensions, nanoemulsions, nanocrystals, and nanoformulations for targeted delivery. Technologies used include nanofabrication techniques, bioconjugation methods, surface modification techniques, molecular imaging techniques, and nanotechnology-based screening methods. Applications include drug delivery systems, diagnostics and imaging, therapeutics, regenerative medicine, and vaccines. End users include hospitals, clinics, research laboratories, pharmaceutical companies, biotechnology firms, and academic institutions.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.

The nanomaterials in personalized medicine market research report is one of a series of new reports from The Business Research Company that provides nanomaterials in personalized medicine market statistics, including nanomaterials in personalized medicine industry global market size, regional shares, competitors with a nanomaterials in personalized medicine market share, detailed nanomaterials in personalized medicine market segments, market trends and opportunities, and any further data you may need to thrive in the nanomaterials in personalized medicine industry. This nanomaterials in personalized medicine market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The nanomaterials in personalized medicine market size has grown rapidly in recent years. It will grow from $351.41 billion in 2024 to $392.97 billion in 2025 at a compound annual growth rate (CAGR) of 11.8%. The growth during the historic period is linked to increasing adoption of nanotechnology in drug delivery, rising demand for targeted therapies, growing awareness of the benefits of personalized medicine, expansion of research in biomarker identification, and higher prevalence of chronic diseases.

The nanomaterials in personalized medicine market size is expected to see rapid growth in the next few years. It will grow to $606.39 billion in 2029 at a compound annual growth rate (CAGR) of 11.5%. The growth projected for the forecast period is driven by growing demand for precision medicine, increasing government funding for nanomedicine, expansion of collaborations between biotech and pharmaceutical companies, rising adoption of advanced diagnostic tools, and greater focus on patient-specific treatments. Primary trends during the forecast period include technological advancements in nanoparticle design, developments in nano-based drug formulations, innovations in targeted delivery systems, increased investment in research and development of personalized therapies, and progress in hybrid nanomaterials for medical applications.

The growing demand for personalized medicine is expected to drive the expansion of the nanomaterials in personalized medicine market in the coming years. Personalized medicine involves customizing treatments for individual patients based on their genetic, environmental, and lifestyle factors to enhance treatment outcomes and quality of care. This demand is increasing due to progress in genomic technologies, which allow for accurate identification of genetic variations and the development of targeted therapies for each person. Nanomaterials play a crucial role in personalized medicine by enabling targeted, patient-specific therapies that enhance the effectiveness and safety of treatments. They facilitate precise delivery of drugs, genes, or RNA, minimizing side effects and maximizing therapeutic results. For example, in February 2024, the Personalized Medicine Coalition, a nonprofit organization based in the US, reported that the U.S. Food and Drug Administration approved 26 new personalized medicines in 2023, compared to 12 approvals in 2022. Hence, the rising demand for personalized medicine is fueling growth in the nanomaterials in personalized medicine market.

Leading companies in this market are concentrating on forming strategic partnerships to speed up clinical translation, broaden therapeutic applications, and reduce time-to-market while adapting to changing regulatory requirements. Strategic collaborations involve combining expertise and resources between companies or institutions to accelerate innovation and expand opportunities in personalized medicine. For instance, in May 2025, Acuitas Therapeutics Inc., a biotechnology firm based in Canada, partnered with Integrated DNA Technologies Inc., a US genomics solutions provider, to launch a personalized CRISPR gene-editing therapy delivery using their lipid nanoparticle platform. This therapy treated a single infant with a rare genetic disorder, employing precisely targeted CRISPR payloads, customized dosing, and rapid formulation. This advancement promotes highly individualized treatments, improving therapeutic precision and patient outcomes, while presenting challenges related to scalable manufacturing, stringent regulatory adaptation, and very low-volume production.

In June 2023, Bayer AG, a pharmaceutical and biotechnology company headquartered in Germany, teamed up with Acuitas Therapeutics Inc. to utilize its lipid nanoparticle delivery technology. This collaboration aims to advance Bayer's in vivo gene editing and protein replacement programs by leveraging Acuitas' lipid nanoparticle platform to deliver RNA efficiently and selectively, especially to the liver. Acuitas Therapeutics Inc. is a Canadian biotechnology company specializing in lipid nanoparticle delivery systems, which are critical nanomaterials for personalized medicine.

Major players in the nanomaterials in personalized medicine market are Pfizer & Co. Inc., BASF SE, Sanofi S.A., The Bristol-Myers Squibb Company, Thermo Fisher Scientific Inc., Abbott Laboratories, Merck KGaA Darmstadt Germany, Evonik Industries AG, Eisai Co. Ltd., TUV Rheinland AG, OCSiAl S.A., American Elements Inc., Cour Pharmaceuticals Inc., Nanocomposix Inc., NoPo Nanotechnologies Private Limited, Matexcel Biotech Inc., OncoNano Medicine Inc., Molecular Rebar Design Inc., Cello Therapeutics Inc., Apurano Pharmaceuticals GmbH, SGN Nanopharma Inc.

North America was the largest region in the nanomaterials in personalized medicine market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in nanomaterials in personalized medicine report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the nanomaterials in personalized medicine market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The nanomaterials in personalized medicine market consists of revenues earned by entities by providing services such as gene and RNA therapy formulation, personalized diagnostic solutions, nanocarrier design and manufacturing, clinical translation support, and custom nanoparticle-based treatment development. The market value includes the value of related goods sold by the service provider or included within the service offering. The nanomaterials in personalized medicine market also includes sales of targeted gene delivery kits, nanoparticle-based diagnostic kits, nanocarrier-enabled vaccine formulations, nano-biosensors, and lab-scale nanofabrication equipment. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Nanomaterials In Personalized Medicine Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on nanomaterials in personalized medicine market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for nanomaterials in personalized medicine ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The nanomaterials in personalized medicine market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Type Of Nanomaterials: Carbon-Based Nanomaterials; Metallic Nanoparticles; Polymeric Nanomaterials; Nanostructured Materials; Silica Nanoparticles
2) By Formulation Type: Nanoparticles; Nanosuspensions; Nanoemulsions; Nanocrystals; Nanoformulations For Targeted Delivery
3) By Technology Utilized: Nanofabrication Techniques; Bioconjugation Methods; Surface Modification Techniques; Molecular Imaging Techniques; Nanotechnology-Based Screening Methods
4) By Application Areas: Drug Delivery Systems; Diagnostics And Imaging; Therapeutics; Regenerative Medicine; Vaccines
5) By End-Users: Hospitals And Clinics; Research Laboratories; Pharmaceutical Companies; Biotechnology Firms; Academic Institutions
Subsegments:
1) By Carbon-Based Nanomaterials: Fullerenes; Carbon Nanotubes; Graphene; Carbon Dots
2) By Metallic Nanoparticles: Gold Nanoparticles; Silver Nanoparticles; Iron Oxide Nanoparticles; Copper Nanoparticles
3) By Polymeric Nanomaterials: Dendrimers; Micelles; Polymeric Nanoparticles; Hydrogels
4) By Nanostructured Materials: Quantum Dots; Nanowires; Nanosheets; Nanorods
5) By Silica Nanoparticles: Mesoporous Silica Nanoparticles; Colloidal Silica Nanoparticles; Porous Silica Nanoparticles; Functionalized Silica Nanoparticles
Companies Mentioned: Pfizer & Co. Inc.; BASF SE; Sanofi S.A.; The Bristol-Myers Squibb Company; Thermo Fisher Scientific Inc.; Abbott Laboratories; Merck KGaA Darmstadt Germany; Evonik Industries AG; Eisai Co. Ltd.; TUV Rheinland AG; OCSiAl S.A.; American Elements Inc.; Cour Pharmaceuticals Inc.; Nanocomposix Inc.; NoPo Nanotechnologies Private Limited; Matexcel Biotech Inc.; OncoNano Medicine Inc.; Molecular Rebar Design Inc.; Cello Therapeutics Inc.; Apurano Pharmaceuticals GmbH; SGN Nanopharma Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.

Product Code: r38582

1. Executive Summary

2. Nanomaterials In Personalized Medicine Market Characteristics

3. Nanomaterials In Personalized Medicine Market Trends And Strategies

4. Nanomaterials In Personalized Medicine Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Nanomaterials In Personalized Medicine Growth Analysis And Strategic Analysis Framework

5.1. Global Nanomaterials In Personalized Medicine PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Nanomaterials In Personalized Medicine Market Growth Rate Analysis
5.4. Global Nanomaterials In Personalized Medicine Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Nanomaterials In Personalized Medicine Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Nanomaterials In Personalized Medicine Total Addressable Market (TAM)

6. Nanomaterials In Personalized Medicine Market Segmentation

6.1. Global Nanomaterials In Personalized Medicine Market, Segmentation By Type Of Nanomaterials, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Carbon-Based Nanomaterials
Metallic Nanoparticles
Polymeric Nanomaterials
Nanostructured Materials
Silica Nanoparticles
6.2. Global Nanomaterials In Personalized Medicine Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Nanoparticles
Nanosuspensions
Nanoemulsions
Nanocrystals
Nanoformulations For Targeted Delivery
6.3. Global Nanomaterials In Personalized Medicine Market, Segmentation By Technology Utilized, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Nanofabrication Techniques
Bioconjugation Methods
Surface Modification Techniques
Molecular Imaging Techniques
Nanotechnology-Based Screening Methods
6.4. Global Nanomaterials In Personalized Medicine Market, Segmentation By Application Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Drug Delivery Systems
Diagnostics And Imaging
Therapeutics
Regenerative Medicine
Vaccines
6.5. Global Nanomaterials In Personalized Medicine Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals And Clinics
Research Laboratories
Pharmaceutical Companies
Biotechnology Firms
Academic Institutions
6.6. Global Nanomaterials In Personalized Medicine Market, Sub-Segmentation Of Carbon-Based Nanomaterials, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Fullerenes
Carbon Nanotubes
Graphene
Carbon Dots
6.7. Global Nanomaterials In Personalized Medicine Market, Sub-Segmentation Of Metallic Nanoparticles, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Gold Nanoparticles
Silver Nanoparticles
Iron Oxide Nanoparticles
Copper Nanoparticles
6.8. Global Nanomaterials In Personalized Medicine Market, Sub-Segmentation Of Polymeric Nanomaterials, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Dendrimers
Micelles
Polymeric Nanoparticles
Hydrogels
6.9. Global Nanomaterials In Personalized Medicine Market, Sub-Segmentation Of Nanostructured Materials, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Quantum Dots
Nanowires
Nanosheets
Nanorods
6.10. Global Nanomaterials In Personalized Medicine Market, Sub-Segmentation Of Silica Nanoparticles, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Mesoporous Silica Nanoparticles
Colloidal Silica Nanoparticles
Porous Silica Nanoparticles
Functionalized Silica Nanoparticles

7. Nanomaterials In Personalized Medicine Market Regional And Country Analysis

7.1. Global Nanomaterials In Personalized Medicine Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Nanomaterials In Personalized Medicine Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Nanomaterials In Personalized Medicine Market

8.1. Asia-Pacific Nanomaterials In Personalized Medicine Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Nanomaterials In Personalized Medicine Market, Segmentation By Type Of Nanomaterials, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Nanomaterials In Personalized Medicine Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Nanomaterials In Personalized Medicine Market, Segmentation By Technology Utilized, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Nanomaterials In Personalized Medicine Market

9.1. China Nanomaterials In Personalized Medicine Market Overview
9.2. China Nanomaterials In Personalized Medicine Market, Segmentation By Type Of Nanomaterials, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Nanomaterials In Personalized Medicine Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Nanomaterials In Personalized Medicine Market, Segmentation By Technology Utilized, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Nanomaterials In Personalized Medicine Market

10.1. India Nanomaterials In Personalized Medicine Market, Segmentation By Type Of Nanomaterials, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Nanomaterials In Personalized Medicine Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Nanomaterials In Personalized Medicine Market, Segmentation By Technology Utilized, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Nanomaterials In Personalized Medicine Market

11.1. Japan Nanomaterials In Personalized Medicine Market Overview
11.2. Japan Nanomaterials In Personalized Medicine Market, Segmentation By Type Of Nanomaterials, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Nanomaterials In Personalized Medicine Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Nanomaterials In Personalized Medicine Market, Segmentation By Technology Utilized, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Nanomaterials In Personalized Medicine Market

12.1. Australia Nanomaterials In Personalized Medicine Market, Segmentation By Type Of Nanomaterials, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Nanomaterials In Personalized Medicine Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Nanomaterials In Personalized Medicine Market, Segmentation By Technology Utilized, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Nanomaterials In Personalized Medicine Market

13.1. Indonesia Nanomaterials In Personalized Medicine Market, Segmentation By Type Of Nanomaterials, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Nanomaterials In Personalized Medicine Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Nanomaterials In Personalized Medicine Market, Segmentation By Technology Utilized, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Nanomaterials In Personalized Medicine Market

14.1. South Korea Nanomaterials In Personalized Medicine Market Overview
14.2. South Korea Nanomaterials In Personalized Medicine Market, Segmentation By Type Of Nanomaterials, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Nanomaterials In Personalized Medicine Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Nanomaterials In Personalized Medicine Market, Segmentation By Technology Utilized, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Nanomaterials In Personalized Medicine Market

15.1. Western Europe Nanomaterials In Personalized Medicine Market Overview
15.2. Western Europe Nanomaterials In Personalized Medicine Market, Segmentation By Type Of Nanomaterials, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Nanomaterials In Personalized Medicine Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Nanomaterials In Personalized Medicine Market, Segmentation By Technology Utilized, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Nanomaterials In Personalized Medicine Market

16.1. UK Nanomaterials In Personalized Medicine Market, Segmentation By Type Of Nanomaterials, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Nanomaterials In Personalized Medicine Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Nanomaterials In Personalized Medicine Market, Segmentation By Technology Utilized, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Nanomaterials In Personalized Medicine Market

17.1. Germany Nanomaterials In Personalized Medicine Market, Segmentation By Type Of Nanomaterials, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Nanomaterials In Personalized Medicine Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Nanomaterials In Personalized Medicine Market, Segmentation By Technology Utilized, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Nanomaterials In Personalized Medicine Market

18.1. France Nanomaterials In Personalized Medicine Market, Segmentation By Type Of Nanomaterials, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Nanomaterials In Personalized Medicine Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Nanomaterials In Personalized Medicine Market, Segmentation By Technology Utilized, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Nanomaterials In Personalized Medicine Market

19.1. Italy Nanomaterials In Personalized Medicine Market, Segmentation By Type Of Nanomaterials, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Nanomaterials In Personalized Medicine Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Nanomaterials In Personalized Medicine Market, Segmentation By Technology Utilized, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Nanomaterials In Personalized Medicine Market

20.1. Spain Nanomaterials In Personalized Medicine Market, Segmentation By Type Of Nanomaterials, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Nanomaterials In Personalized Medicine Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Nanomaterials In Personalized Medicine Market, Segmentation By Technology Utilized, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Nanomaterials In Personalized Medicine Market

21.1. Eastern Europe Nanomaterials In Personalized Medicine Market Overview
21.2. Eastern Europe Nanomaterials In Personalized Medicine Market, Segmentation By Type Of Nanomaterials, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Nanomaterials In Personalized Medicine Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Nanomaterials In Personalized Medicine Market, Segmentation By Technology Utilized, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Nanomaterials In Personalized Medicine Market

22.1. Russia Nanomaterials In Personalized Medicine Market, Segmentation By Type Of Nanomaterials, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Nanomaterials In Personalized Medicine Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Nanomaterials In Personalized Medicine Market, Segmentation By Technology Utilized, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Nanomaterials In Personalized Medicine Market

23.1. North America Nanomaterials In Personalized Medicine Market Overview
23.2. North America Nanomaterials In Personalized Medicine Market, Segmentation By Type Of Nanomaterials, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Nanomaterials In Personalized Medicine Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Nanomaterials In Personalized Medicine Market, Segmentation By Technology Utilized, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Nanomaterials In Personalized Medicine Market

24.1. USA Nanomaterials In Personalized Medicine Market Overview
24.2. USA Nanomaterials In Personalized Medicine Market, Segmentation By Type Of Nanomaterials, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Nanomaterials In Personalized Medicine Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Nanomaterials In Personalized Medicine Market, Segmentation By Technology Utilized, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Nanomaterials In Personalized Medicine Market

25.1. Canada Nanomaterials In Personalized Medicine Market Overview
25.2. Canada Nanomaterials In Personalized Medicine Market, Segmentation By Type Of Nanomaterials, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Nanomaterials In Personalized Medicine Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Nanomaterials In Personalized Medicine Market, Segmentation By Technology Utilized, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Nanomaterials In Personalized Medicine Market

26.1. South America Nanomaterials In Personalized Medicine Market Overview
26.2. South America Nanomaterials In Personalized Medicine Market, Segmentation By Type Of Nanomaterials, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Nanomaterials In Personalized Medicine Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Nanomaterials In Personalized Medicine Market, Segmentation By Technology Utilized, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Nanomaterials In Personalized Medicine Market

27.1. Brazil Nanomaterials In Personalized Medicine Market, Segmentation By Type Of Nanomaterials, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Nanomaterials In Personalized Medicine Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Nanomaterials In Personalized Medicine Market, Segmentation By Technology Utilized, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Nanomaterials In Personalized Medicine Market

28.1. Middle East Nanomaterials In Personalized Medicine Market Overview
28.2. Middle East Nanomaterials In Personalized Medicine Market, Segmentation By Type Of Nanomaterials, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Nanomaterials In Personalized Medicine Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Nanomaterials In Personalized Medicine Market, Segmentation By Technology Utilized, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Nanomaterials In Personalized Medicine Market

29.1. Africa Nanomaterials In Personalized Medicine Market Overview
29.2. Africa Nanomaterials In Personalized Medicine Market, Segmentation By Type Of Nanomaterials, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Nanomaterials In Personalized Medicine Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Nanomaterials In Personalized Medicine Market, Segmentation By Technology Utilized, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Nanomaterials In Personalized Medicine Market Competitive Landscape And Company Profiles

30.1. Nanomaterials In Personalized Medicine Market Competitive Landscape
30.2. Nanomaterials In Personalized Medicine Market Company Profiles
- 30.2.1. Pfizer & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. BASF SE Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. The Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Nanomaterials In Personalized Medicine Market Other Major And Innovative Companies

31.1. Abbott Laboratories
31.2. Merck KGaA Darmstadt Germany
31.3. Evonik Industries AG
31.4. Eisai Co. Ltd.
31.5. TUV Rheinland AG
31.6. OCSiAl S.A.
31.7. American Elements Inc.
31.8. Cour Pharmaceuticals Inc.
31.9. Nanocomposix Inc.
31.10. NoPo Nanotechnologies Private Limited
31.11. Matexcel Biotech Inc.
31.12. OncoNano Medicine Inc.
31.13. Molecular Rebar Design Inc.
31.14. Cello Therapeutics Inc.
31.15. Apurano Pharmaceuticals GmbH

32. Global Nanomaterials In Personalized Medicine Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Nanomaterials In Personalized Medicine Market

34. Recent Developments In The Nanomaterials In Personalized Medicine Market

35. Nanomaterials In Personalized Medicine Market High Potential Countries, Segments and Strategies

35.1 Nanomaterials In Personalized Medicine Market In 2029 - Countries Offering Most New Opportunities
35.2 Nanomaterials In Personalized Medicine Market In 2029 - Segments Offering Most New Opportunities
35.3 Nanomaterials In Personalized Medicine Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer